Cite
Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection
MLA
Sina Ghiassinejad, et al. “Codelivery of Paclitaxel and Temozolomide through a Photopolymerizable Hydrogel Prevents Glioblastoma Recurrence after Surgical Resection.” Journal of Controlled Release : Official Journal of the Controlled Release Society, vol. 309, Apr. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b8fc3d487ef77864f57267c12773c932&authtype=sso&custid=ns315887.
APA
Sina Ghiassinejad, Elia Bozzato, Bernard Gallez, Véronique Préat, Nicolas Joudiou, Mengnan Zhao, & Fabienne Danhier. (2019). Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection. Journal of Controlled Release : Official Journal of the Controlled Release Society, 309.
Chicago
Sina Ghiassinejad, Elia Bozzato, Bernard Gallez, Véronique Préat, Nicolas Joudiou, Mengnan Zhao, and Fabienne Danhier. 2019. “Codelivery of Paclitaxel and Temozolomide through a Photopolymerizable Hydrogel Prevents Glioblastoma Recurrence after Surgical Resection.” Journal of Controlled Release : Official Journal of the Controlled Release Society 309 (April). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b8fc3d487ef77864f57267c12773c932&authtype=sso&custid=ns315887.